Abstract: An endovascular treatment mesh device for closing outpouchings by affixing at least one amorphous hydrogel layer expandable in vivo to any or all surfaces of an expandable body comprising at least one material adapted to close said outpouching in the body. The treatment mesh further includes a telescoping center-support bar disposed therein, the center-support bar having at least two telescoping elements that act as reinforcing extension elements to minimize the risk of collapse. Hydrogel is affixed to the surface of the telescoping elements to inhibit retraction. An embodiment wherein the treatment mesh device is a stent.

Abstract: A method to close bodily outpouchings using a novel endovascular treatment mesh device that affixes at least one amorphous hydrogel layer expandable in vivo to any or all surfaces of an expandable body comprising at least one material adapted to close said outpouching in the body. The treatment mesh further includes a telescoping center-support bar disposed therein, the center-support bar having at least two telescoping elements that act as reinforcing extension elements to minimize the risk of collapse. Hydrogel is affixed to the surface of the telescoping elements to inhibit retraction. The method includes use of an embodiment of the novel device wherein the treatment mesh device is a stent.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate endovascular treatment related difficulties.

Abstract: A balloon catheter for treating aneurysms or other intraluminal target sites, having at least one bypass window through which blood flows temporarily and out at least one end hole, and a balloon mounted near the end hole, such that there is no need for repeated inflation/deflation cycles. The invention has an elongated tube, a balloon disposed between the most distal said window and said end hole, and at least two channels. A first channel passes from the proximal end of said tube to the bypass window to allow blood to flow into said window and out said end hole, and a second channel passing from the proximal end of said tube to said balloon to allow inflation material to enter said balloon.

Abstract: A method for transfemoral percutaneous establishment of retrograde blood flow. More particularly, a transfemoral percutaneous approach to an interventional procedure on the neurovasculature performed through a transfemoral access while retrograde blood flow is established from the internal vessel artery to a second vessel.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate endovascular treatment related difficulties.

Abstract: Micro-catheters and embolic agents offer better results in endovascular treatment of brain arteriovenous malformations. Using said micro-catheters and embolic agents generally requires the creating of a plug at the distal-most portion of said micro-catheters which regularly results in suboptimal results. The present invention teaches how to create and use a device which creates a plug downstream of the distal-most portion of said micro-catheters and thereby ameliorates the suboptimal outcomes associated with creating a plug at the distal-most portion of said micro-catheters.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate endovascular treatment related difficulties.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate endovascular treatment related difficulties.

Abstract: An anchored exchange wire and optional filter assembly and method comprising a wire, with or without a temporary filter, anchored and fixed in position by an attached self-expanding stent. The device is designed to facilitate the safer delivery of endovascular devices over the wire, while minimizing risks that can be associated with unwanted movement of the associated wire and/or filter.

Abstract: A balloon catheter for treating aneurysms or other intraluminal target sites, having at least one bypass window through which blood flows temporarily and out at least one end hole, and a balloon mounted near the end hole, such that there is no need for repeated inflation/-deflation cycles. The invention has an elongated tube, a balloon disposed between the most distal said window and said end hole, and at least two channels. A first channel passes from the proximal end of said tube to the bypass window to allow blood to flow into said window and out said end hole, and a second channel passing from the proximal end of said tube to said balloon to allow inflation material to enter said balloon.

Abstract: Micro-catheters and embolic agents offer better results in endovascular treatment of brain arteriovenous malformations. Using said micro-catheters and embolic agents generally requires the creating of a plug at the distal-most portion of said micro-catheters which regularly results in suboptimal results. The present invention teaches how to create and use a device which creates a plug downstream of the distal-most portion of said micro-catheters and thereby ameliorates the suboptimal outcomes associated with creating a plug at the distal-most portion of said micro-catheters.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate endovascular treatment related difficulties.

Abstract: The present disclosure relates to the field of medical treatment. More particularly, the current invention delivers medication via a coating via a hydrogel infused with pharmaceutical compounds into the bloodstream to promote the supply to the distal vascular bed beyond the stent. The present invention uses in a preferred embodiment a stent with a thin coating of biodegradable or non-biodegradable hydrogel designed to ameliorate or eliminate vasospasms or thromboses, or to treat cancer, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate treatment related difficulties.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate endovascular treatment related difficulties.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention discloses a tool designed to implement an endovascular treatment capable of delivering medicine, such as amorphous hydrogel to wounds proximate to injury caused by endovascular treatment. Said hydrogel is affixed to an endovascular device.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate endovascular treatment related difficulties.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate endovascular treatment related difficulties.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate endovascular treatment related difficulties.

Abstract: The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be impregnated with pharmaceutical compounds. The present invention also teaches the use of thin hydrogel coatings to ameliorate endovascular treatment related difficulties.